Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy

• Hakim Echchannaoui,
• Hakim Echchannaoui,
• Matthieu Perreau,
• Hansjörg Schild,
• Hansjörg Schild,
• Matthias Theobald,
• Matthias Theobald,
• Matthias Theobald

Affiliations

Hakim Echchannaoui

Department of Hematology and Medical Oncology, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany

Hakim Echchannaoui

German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, Mainz, Germany

Matthieu Perreau

Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland

Hansjörg Schild

Institute of Immunology, UMC of the Johannes Gutenberg University, Mainz, Germany

Hansjörg Schild

Helmholtz Institute Translational Oncology (HI-TRON), Mainz, Germany

Matthias Theobald

Department of Hematology and Medical Oncology, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany

Matthias Theobald

German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, Mainz, Germany

Matthias Theobald

Institute of Immunology, UMC of the Johannes Gutenberg University, Mainz, Germany